To address the therapeutic potential of restoring TFEB levels in a clinically relevant mouse model of MSA, we aimed at overexpressing TFEB in a transgenic mouse model of MSA expressing human WT α-syn under the control of the oligodendrocyte-specific promoter PLP (hereafter referred as PLP mice) (29–33). This evidence concerns the gene TFEB and multiple system atrophy.